Cancer Council NSW logo
13 11 20 Information & Support
Give monthly
Menu
  • Cancer Information
    • By cancer type
      • Bowel cancer
      • Blood cancers
      • Breast cancer
      • Lung cancer
      • Melanoma
      • Prostate cancer
      • View 26 other cancers
    • General information
      • What is cancer?
      • When you are first diagnosed
      • Cancer treatment
      • Managing side effects
      • Living well
      • Practical concerns
      • Advanced cancer
    • How can we help you?
      • Carers
      • Family and friends
      • Multilingual cancer information
      • Schools and teachers
    • More resources
      • Understanding Cancer books
      • Podcast: The Thing About Cancer
      • Podcast: The Thing About Advanced Cancer
      • Cancer Information Services
      • Cancer information for Aboriginal & Torres Strait Islander people
  • Get Support
    • How can we help you
      • 13 11 20 – Speak to a cancer professional
      • Connect with others
      • Cancer Counselling
      • Pro Bono Program
      • Financial Assistance
      • Transport to cancer treatment
      • Accommodation during cancer treatment
      • Support for cancer survivors
    • More information
      • Information for health professionals
      • Aboriginal & Torres Strait Islander people
      • Multilingual cancer information
      • LGBTI
      • Cancer and COVID-19 in NSW
      • Webinars
  • Cancer Prevention
    • By topic
      • Alcohol
      • Diet and exercise
      • Screening and early detection
      • Smoking
      • Sun protection
    • Programs
      • SunSmart NSW website
      • Improve your long game
      • Tackling Tobacco
  • Research
    • By Topic
      • Research we conduct
      • Research we fund
      • Information for researchers
      • Community Involvement in Research
    • Quick links
      • Search research by cancer type or topic
      • Research Grant Applications
      • Research Achievements
  • Get Involved
    • How will you get involved
      • Volunteer with us
      • Work with us
      • Fundraise for us
      • Partner with us
      • Campaign with us
      • Shop with us
    • Quick Links
      • Events calendar
      • Request a Cancer Council Talk
      • Share your story
      • Supporter Recognition
  • Donate
    • Donate today
    • Donate monthly
    • Donate in memory
    • Leave a gift in your will
    • More ways to donate
  • Cancer Information
    • By cancer type
      • Bowel cancer
      • Blood cancers
      • Breast cancer
      • Lung cancer
      • Melanoma
      • Prostate cancer
      • View 26 other cancers
    • General information
      • What is cancer?
      • When you are first diagnosed
      • Cancer treatment
      • Managing side effects
      • Living well
      • Practical concerns
      • Advanced cancer
    • How can we help you?
      • Carers
      • Family and friends
      • Multilingual cancer information
      • Schools and teachers
    • More resources
      • Understanding Cancer books
      • Podcast: The Thing About Cancer
      • Podcast: The Thing About Advanced Cancer
      • Cancer Information Services
      • Cancer information for Aboriginal & Torres Strait Islander people
  • Get Support
    • How can we help you
      • 13 11 20 – Speak to a cancer professional
      • Connect with others
      • Cancer Counselling
      • Pro Bono Program
      • Financial Assistance
      • Transport to cancer treatment
      • Accommodation during cancer treatment
      • Support for cancer survivors
    • More information
      • Information for health professionals
      • Aboriginal & Torres Strait Islander people
      • Multilingual cancer information
      • LGBTI
      • Cancer and COVID-19 in NSW
      • Webinars
  • Cancer Prevention
    • By topic
      • Alcohol
      • Diet and exercise
      • Screening and early detection
      • Smoking
      • Sun protection
    • Programs
      • SunSmart NSW website
      • Improve your long game
      • Tackling Tobacco
  • Research
    • By Topic
      • Research we conduct
      • Research we fund
      • Information for researchers
      • Community Involvement in Research
    • Quick links
      • Search research by cancer type or topic
      • Research Grant Applications
      • Research Achievements
  • Get Involved
    • How will you get involved
      • Volunteer with us
      • Work with us
      • Fundraise for us
      • Partner with us
      • Campaign with us
      • Shop with us
    • Quick Links
      • Events calendar
      • Request a Cancer Council Talk
      • Share your story
      • Supporter Recognition
  • Donate
    • Donate today
    • Donate monthly
    • Donate in memory
    • Leave a gift in your will
    • More ways to donate
  • Home
  • Pancreatic cancer
  • Research
  • Monitoring a patient’s real-time response to a new immunotherapy

Monitoring a patient’s real-time response to a new immunotherapy

Professor John Rasko
Professor John Rasko AO Centenary Institute $448,850 2020 – 2022

Background

Pancreatic cancer and asbestos-induced lung cancer (mesothelioma) both have poor five-year survival rates of less than 10% due to a lack of effective treatments. Over 3,300 and 700 new cases of pancreatic cancer and asbestos-induced lung cancer, respectively, are diagnosed in Australia each year. By 2030, pancreatic cancer is predicted to become our second leading cause of cancer death. 

The research

This project will complement a major Cancer Council NSW funded project in which Professor John Rasko and his research team are trialling a potential new treatment for pancreatic cancer and mesothelioma known as CAR T-cell immunotherapy. CAR T-cell immunotherapy has shown unprecedented success in patients with some blood cancers, including acute lymphoblastic leukaemia. Professor Rasko’s project is the first in Australia to test this treatment approach in a solid tumour.  

In this project, Professor Rasko and his team will develop a way of monitoring the success or failure of standard treatments or CAR T-cell immunotherapy by collecting circulating tumour cells – cancer cells found in the bloodstream.  These rare cells may only be present at one in a billion other white blood cells are nonetheless easy to collect and can be repeatedly sampled throughout the course of treatment. The cells will be analysed in the laboratory not only to monitor the effectiveness of the treatment but also identify when and why treatment-resistance develops. The team can then use this information to develop strategies to address recurrent cancers. 

The impact

The project will positively impact the treatment a patient receives by monitoring an individual’s response to therapy and uncovering how the cancer cells become resistant to treatment. 

This exciting new approach will provide the basis of predicting which patients will benefit from CAR-T cell immunotherapy in the future. The team hopes to extend this strategy to other cancer types and create a decision-making flow chart for clinicians to use when deciding which patients are eligible for immunotherapy.  

Search research
Cancer research depends on your support
Give monthly
Share

Achievements
18 Jun 2020

Addressing the needs of long-term prostate cancer survivors

Find out more
20 May 2020

HPV vaccine linked to decline in premature births

Find out more
Latest news
19 Jul 2021

ROSA – A roadmap for individualised breast screening

Find out more
  • About us
  • News & Media
  • Cancer Council Shop
  • Contact us
  • Work with us
  • Privacy and website policies
Aboriginal Daffodil logo

Cancer Council NSW acknowledges the traditional custodians of the land on which we live and work. We pay our respects to the elders past and present and extend that respect to all other Aboriginal and Torres Strait Islander peoples.

Registered Charity (ACNC)

© Cancer Council NSW 2021. Cancer Council NSW is registered with the Australian Taxation Office as an Income Tax Exempt Charity: Charitable Fundraising Authority No. 18521. ABN 51 116 463 846. Cancer Council NSW, 153 Dowling Street, Woolloomooloo NSW 2011. All donations over $2 are tax deductible.